# Diclofenac vs. Ropivacaine for Cesarean Section

> **NCT00801528** · PHASE4 · COMPLETED · sponsor: **Meir Medical Center** · enrollment: 75 (estimated)

## Conditions studied

- Cesarean Section

## Interventions

- **DRUG:** Ropivacaine, Diclofenac, Water for injection

## Key facts

- **NCT ID:** NCT00801528
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2010-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801528, "Diclofenac vs. Ropivacaine for Cesarean Section". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00801528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*